Drug intelligence / Profile preview

grass pollen sublingual immunotherapy

Development stage
Unknown
Lead developer
Stallergenes Greer
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Sublingual
01

Overview

Grass pollen sublingual immunotherapy (SLIT) is a therapeutic modality used to treat allergic rhinitis and conjunctivitis induced by grass pollen. It involves the administration of standardized allergen extracts from various grass species (such as Kentucky blue grass, orchard, perennial rye, timothy, and sweet vernal grass) in the form of tablets or drops placed under the tongue. The treatment works by inducing immunotolerance through the modulation of the immune system's response to allergens. Specifically, it promotes the production of protective IgG4 antibodies and reduces the levels of allergen-specific IgE, thereby decreasing the inflammatory response upon natural exposure to grass pollen. Major products in this category include Oralair (developed by Stallergenes Greer) and Grastek/Grazax (developed by ALK-Abelló).

Brand names
OralairGrastekGrazax
Other names
Grass-SLITGrass pollen SLIT5-grass pollen sublingual immunotherapy
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on grass pollen sublingual immunotherapy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on grass pollen sublingual immunotherapy.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call